{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:12:06Z","timestamp":1793160726560,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-021-00240-6","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T16:05:29Z","timestamp":1629129929000},"page":"962-977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-0517","authenticated-orcid":false,"given":"Yosuke","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-9157","authenticated-orcid":false,"given":"Fumiko","family":"Chiwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-7298","authenticated-orcid":false,"given":"Toshihide","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Matsusaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-707X","authenticated-orcid":false,"given":"Narikazu","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yatabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9443-0364","authenticated-orcid":false,"given":"Hiroki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4645-0181","authenticated-orcid":false,"given":"Hiroyuki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"240_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"240_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64, 31\u201349 (1965).","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"240_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu, R. et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat. Med. 21, 449\u2013456 (2015).","journal-title":"Nat. Med."},{"key":"240_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi, B. et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88, 358\u2013363 (2000).","journal-title":"Cancer"},{"key":"240_CR5","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.3748\/wjg.v22.i33.7478","volume":"22","author":"J Wei","year":"2016","unstructured":"Wei, J., Wu, N.-D. & Liu, B.-R. Regional but fatal: intraperitoneal metastasis in gastric cancer. World J. Gastroenterol. 22, 7478\u20137485 (2016).","journal-title":"World J. Gastroenterol."},{"key":"240_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network.","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209 (2014).","journal-title":"Nature"},{"key":"240_CR7","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa2004413","volume":"382","author":"K Shitara","year":"2020","unstructured":"Shitara, K. et al. Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer. N. Engl. J. Med. 382, 2419\u20132430 (2020).","journal-title":"N. Engl. J. Med."},{"key":"240_CR8","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"Y-K Kang","year":"2017","unstructured":"Kang, Y.-K. et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390, 2461\u20132471 (2017).","journal-title":"Lancet"},{"key":"240_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","volume":"69","author":"R Wang","year":"2020","unstructured":"Wang, R. et al. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 69, 18\u201331 (2020).","journal-title":"Gut"},{"key":"240_CR10","doi-asserted-by":"publisher","first-page":"43894","DOI":"10.18632\/oncotarget.9707","volume":"7","author":"H Liu","year":"2016","unstructured":"Liu, H. et al. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: a preliminary study. Oncotarget 7, 43894\u201343906 (2016).","journal-title":"Oncotarget"},{"key":"240_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13577-018-0211-4","volume":"31","author":"M Yashiro","year":"2018","unstructured":"Yashiro, M., Matsuoka, T. & Ohira, M. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models. Hum. Cell 31, 271\u2013281 (2018).","journal-title":"Hum. Cell"},{"key":"240_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","volume":"27","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat. Med. 27, 141\u2013151 (2021).","journal-title":"Nat. Med."},{"key":"240_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"240_CR14","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.cell.2018.06.001","volume":"173","author":"I Martincorena","year":"2018","unstructured":"Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 173, 1823 (2018).","journal-title":"Cell"},{"key":"240_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41588-019-0572-y","volume":"52","author":"F Dietlein","year":"2020","unstructured":"Dietlein, F. et al. Identification of cancer driver genes based on nucleotide context. Nat. Genet. 52, 208\u2013218 (2020).","journal-title":"Nat. Genet."},{"key":"240_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","volume":"46","author":"K Wang","year":"2014","unstructured":"Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573\u2013582 (2014).","journal-title":"Nat. Genet."},{"key":"240_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"240_CR18","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","volume":"21","author":"A Marabelle","year":"2020","unstructured":"Marabelle, A. et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol. 21, 1353\u20131365 (2020).","journal-title":"Lancet Oncol."},{"key":"240_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ng.2984","volume":"46","author":"M Kakiuchi","year":"2014","unstructured":"Kakiuchi, M. et al. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat. Genet. 46, 583\u2013587 (2014).","journal-title":"Nat. Genet."},{"key":"240_CR20","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/onc.2016.473","volume":"36","author":"I Zandvakili","year":"2017","unstructured":"Zandvakili, I., Lin, Y., Morris, J. C. & Zheng, Y. Rho GTPases: anti- or pro-neoplastic targets? Oncogene 36, 3213\u20133222 (2017).","journal-title":"Oncogene"},{"key":"240_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ccell.2018.10.003","volume":"34","author":"CM Bielski","year":"2018","unstructured":"Bielski, C. M. et al. Widespread selection for oncogenic mutant allele imbalance in cancer. Cancer Cell 34, 852\u2013862.e4 (2018).","journal-title":"Cancer Cell"},{"key":"240_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41586-019-1856-1","volume":"577","author":"N Kakiuchi","year":"2020","unstructured":"Kakiuchi, N. et al. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Nature 577, 260\u2013265 (2020).","journal-title":"Nature"},{"key":"240_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4049\/jimmunol.175.1.376","volume":"175","author":"TA Schneeman","year":"2005","unstructured":"Schneeman, T. A. et al. Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4: linking innate and adaptive immune responses. J. Immunol. 175, 376\u2013384 (2005).","journal-title":"J. Immunol."},{"key":"240_CR24","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/hep.29036","volume":"65","author":"X Yue","year":"2017","unstructured":"Yue, X. et al. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. Hepatology 65, 1948\u20131962 (2017).","journal-title":"Hepatology"},{"key":"240_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0480-5","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu, Y. et al. FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol. 15, 480 (2014).","journal-title":"Genome Biol."},{"key":"240_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41525-020-0133-4","volume":"5","author":"YA Guo","year":"2020","unstructured":"Guo, Y. A., Chang, M. M. & Skanderup, A. J. MutSpot: detection of non-coding mutation hotspots in cancer genomes. NPJ Genom. Med. 5, 26 (2020).","journal-title":"NPJ Genom. Med."},{"key":"240_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03828-2","volume":"9","author":"YA Guo","year":"2018","unstructured":"Guo, Y. A. et al. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers. Nat. Commun. 9, 1520 (2018).","journal-title":"Nat. Commun."},{"key":"240_CR28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189\u20131195 (2018).","journal-title":"Nat. Genet."},{"key":"240_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"240_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06747-4","volume":"9","author":"H Yang","year":"2018","unstructured":"Yang, H. et al. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer. Nat. Commun. 9, 4439 (2018).","journal-title":"Nat. Commun."},{"key":"240_CR31","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1245\/s10434-015-4376-8","volume":"22","author":"HJ Chon","year":"2015","unstructured":"Chon, H. J. et al. The clinicopathologic features and prognostic impact of ALK positivity in patients with resected gastric cancer. Ann. Surg. Oncol. 22, 3938\u20133945 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"240_CR32","doi-asserted-by":"publisher","first-page":"e27707","DOI":"10.1002\/pbc.27707","volume":"66","author":"L Sisdelli","year":"2019","unstructured":"Sisdelli, L. et al. AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma. Pediatr. Blood Cancer 66, e27707 (2019).","journal-title":"Pediatr. Blood Cancer"},{"key":"240_CR33","doi-asserted-by":"publisher","first-page":"a022277","DOI":"10.1101\/cshperspect.a022277","volume":"9","author":"J Seoane","year":"2017","unstructured":"Seoane, J. & Gomis, R. R. TGF-\u03b2 family signaling in tumor suppression and cancer progression. Cold Spring Harb. Perspect. Biol. 9, a022277 (2017).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"240_CR34","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1158\/0008-5472.CAN-18-3210","volume":"79","author":"S Sakai","year":"2019","unstructured":"Sakai, S. et al. Long noncoding RNA ELIT-1 acts as a Smad3 cofactor to facilitate TGF\u03b2\/Smad signaling and promote epithelial\u2013mesenchymal transition. Cancer Res. 79, 2821\u20132838 (2019).","journal-title":"Cancer Res."},{"key":"240_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246\u2013257 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"240_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503\u2013508 (2019).","journal-title":"Nature"},{"key":"240_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"240_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307\u2013319 (2013).","journal-title":"Cell"},{"key":"240_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1101\/gr.197590.115","volume":"26","author":"V Saint-Andr\u00e9","year":"2016","unstructured":"Saint-Andr\u00e9, V. et al. Models of human core transcriptional regulatory circuitries. Genome Res. 26, 385\u2013396 (2016).","journal-title":"Genome Res."},{"key":"240_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2018-317612","volume":"69","author":"WF Ooi","year":"2020","unstructured":"Ooi, W. F. et al. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma. Gut 69, 1039\u20131052 (2020).","journal-title":"Gut"},{"key":"240_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.CD-17-0532","volume":"8","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Somatic superenhancer duplications and hotspot mutations lead to oncogenic activation of the KLF5 transcription factor. Cancer Discov. 8, 108\u2013125 (2018).","journal-title":"Cancer Discov."},{"key":"240_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376\u2013380 (2012).","journal-title":"Nature"},{"key":"240_CR43","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/2159-8290.CD-19-0442","volume":"9","author":"J Lee","year":"2019","unstructured":"Lee, J. et al. Tumor genomic profiling guides patients with metastatic gastric cancer to targeted treatment: the VIKTORY umbrella trial. Cancer Discov. 9, 1388\u20131405 (2019).","journal-title":"Cancer Discov."},{"key":"240_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04179-8","volume":"9","author":"SC Oh","year":"2018","unstructured":"Oh, S. C. et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat. Commun. 9, 1777 (2018).","journal-title":"Nat. Commun."},{"key":"240_CR45","first-page":"4399","volume":"10","author":"A Kaneda","year":"2020","unstructured":"Kaneda, A. et al. The novel potent TEAD inhibitor, K-975, inhibits YAP1\/TAZ-TEAD protein\u2013protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma. Am. J. Cancer Res. 10, 4399\u20134415 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"240_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","volume":"37","author":"KJ Kurppa","year":"2020","unstructured":"Kurppa, K. J. et al. Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell 37, 104\u2013122.e12 (2020).","journal-title":"Cancer Cell"},{"key":"240_CR47","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ng.3218","volume":"47","author":"L Lin","year":"2015","unstructured":"Lin, L. et al. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat. Genet. 47, 250\u2013256 (2015).","journal-title":"Nat. Genet."},{"key":"240_CR48","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1053\/j.gastro.2017.05.012","volume":"153","author":"SY Cho","year":"2017","unstructured":"Cho, S. Y. et al. Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers. Gastroenterology 153, 536\u2013549.e26 (2017).","journal-title":"Gastroenterology"},{"key":"240_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel, P. M. & Massagu\u00e9, J. Cytostatic and apoptotic actions of TGF-\u03b2 in homeostasis and cancer. Nat. Rev. Cancer 3, 807\u2013821 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"240_CR50","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/gutjnl-2019-318325","volume":"69","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma. Gut 69, 630\u2013640 (2020).","journal-title":"Gut"},{"key":"240_CR51","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami, H. et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC Trial. J. Clin. Oncol. 36, 1922\u20131929 (2018).","journal-title":"J. Clin. Oncol."},{"key":"240_CR52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","volume":"25","author":"S Jiao","year":"2014","unstructured":"Jiao, S. et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 25, 166\u2013180 (2014).","journal-title":"Cancer Cell"},{"key":"240_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/gutjnl-2019-319748","volume":"70","author":"JA Ajani","year":"2021","unstructured":"Ajani, J. A. et al. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut 70, 55\u201366 (2021).","journal-title":"Gut"},{"key":"240_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10147-011-0199-1","volume":"16","author":"K Matsusaki","year":"2011","unstructured":"Matsusaki, K., Ohta, K., Yoshizawa, A. & Gyoda, Y. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives. Int. J. Clin. Oncol. 16, 395\u2013400 (2011).","journal-title":"Int. J. Clin. Oncol."},{"key":"240_CR55","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"240_CR56","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/nar\/gkt126","volume":"41","author":"Y Shiraishi","year":"2013","unstructured":"Shiraishi, Y. et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic Acids Res. 41, e89 (2013).","journal-title":"Nucleic Acids Res."},{"key":"240_CR57","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"240_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-6041-2","volume":"20","author":"EN Bergstrom","year":"2019","unstructured":"Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics 20, 685 (2019).","journal-title":"BMC Genomics"},{"key":"240_CR59","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1101\/gr.092981.109","volume":"19","author":"S Yoon","year":"2009","unstructured":"Yoon, S., Xuan, Z., Makarov, V., Ye, K. & Sebat, J. Sensitive and accurate detection of copy number variants using read depth of coverage. Genome Res. 19, 1586\u20131592 (2009).","journal-title":"Genome Res."},{"key":"240_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"240_CR61","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"240_CR62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nmeth.2883","volume":"11","author":"A Roth","year":"2014","unstructured":"Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396\u2013398 (2014).","journal-title":"Nat. Methods"},{"key":"240_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"240_CR64","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511\u2013515 (2010).","journal-title":"Nat. Biotechnol."},{"key":"240_CR65","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760\u20131774 (2012).","journal-title":"Genome Res."},{"key":"240_CR66","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"240_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP\u2013Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00240-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00240-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00240-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T21:16:32Z","timestamp":1670102192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00240-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["240"],"URL":"https:\/\/doi.org\/10.1038\/s43018-021-00240-6","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"2 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}